Europe Autoimmunity Diagnostics Market (2025-2030)
The Europe Autoimmunity Diagnostics Market was valued at $1216 Million in 2025 and projected to reach to $1986 Million by 2030, representing a compound annual growth rate of 8.5%. Europe's autoimmunity diagnostics market is positioned for sustained growth, expanding from $1,216 million in 2025 to $1,986 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Autoimmunity Diagnostics Market Trends and Insights
- This 8.5% compound annual growth rate reflects Europe's strong healthcare infrastructure, rising prevalence of autoimmune disorders, and increasing adoption of advanced diagnostic technologies across the region.
- Europe's mature healthcare systems and regulatory frameworks support widespread deployment of innovative testing solutions, positioning the continent as a key growth driver in the global autoimmunity diagnostics landscape. The European market benefits from high healthcare spending, well-established diagnostic laboratory networks, and growing patient awareness of autoimmune conditions.
- Europe's aging population and improved disease recognition contribute to increased demand for accurate and early diagnostic tools.
- Between 2025 and 2030, Europe is expected to capture significant market share through investments in point-of-care testing, multiplex assays, and digital health integration, reinforcing the region's leadership in precision diagnostics..
Key Market Statistics
- CAGR (2025-2030) 8.5% CAGR
- Market Size, 2025 ~USD 1216 Million
- Forecast, 2030 ~USD 1986 Million
- Geography Europe
Europe Autoimmunity Diagnostics Market Overview
Strong Market Valuation :
Europe's autoimmunity diagnostics market is valued at $1,216 million in 2025, reflecting the region's significant healthcare investment and high disease prevalence across multiple autoimmune conditions.
Robust Growth Trajectory :
With an 8.5% CAGR through 2030, Europe's market growth outpaces the global average of 8.3%, driven by advanced healthcare infrastructure and increasing diagnostic adoption across Western and Central European nations.
Mature Healthcare Systems :
Europe's well-established healthcare infrastructure, regulatory frameworks, and reimbursement policies create a favorable environment for innovative autoimmunity diagnostic technologies and market expansion.
Rising Disease Prevalence :
Increasing prevalence of autoimmune disorders across Europe, combined with growing awareness and early detection initiatives, is driving demand for advanced diagnostic solutions and testing capabilities.
Europe Autoimmunity Diagnostics Market Dynamics
- This expansion is underpinned by Europe's mature healthcare systems, strong regulatory frameworks, and increasing prevalence of autoimmune diseases across the region.
- Advanced diagnostic technologies, including multiplex assays and point-of-care testing, are gaining traction in European healthcare settings. Key growth drivers include rising healthcare expenditure, improved patient awareness, and the adoption of precision medicine approaches.
- European countries are increasingly investing in early diagnosis and personalized treatment strategies, creating opportunities for innovative diagnostic solutions.
- The region's aging population and lifestyle factors further contribute to growing autoimmune disease incidence, supporting sustained market demand through 2030..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Merck KGaA
- Shimadzu Corporation
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Europe's autoimmunity diagnostics market will grow from $1,216M (2025) to $1,986M (2030) at an 8.5% CAGR.
- Europe's mature healthcare infrastructure and high diagnostic spending drive adoption of advanced autoimmunity testing solutions.
- Rising autoimmune disease prevalence and aging populations across Europe fuel demand for early and accurate diagnostic tools.
- Europe leads in regulatory compliance and digital health integration, supporting innovation in multiplex and point-of-care diagnostics.
Autoimmunity Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AUTOANTIBODIES AND IMMUNOLOGIC TESTS (Test Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 5.57 (2025) |
| Revenue Forecast (Billions) | ~USD 8.29 (2030) |
| Segments Covered | Product, Test Type, Disease Type, Type, End User |
Europe Autoimmunity Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Test Type
- Autoantibodies And Immunologic Tests
- Inflammatory Tests
- Other Tests
- Routine Laboratory Tests
- Urinalysis Tests
By Disease Type
- Organ-Specific Autoimmune Diseases
- Systemic Autoimmune Diseases
By Type
- Celiac Disease
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Other Organ-Specific Autoimmune Diseases
- Other Systemic Autoimmune Diseases
- Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Type-1 Diabetes
By End User
- Clinical Laboratories
- Hospitals & Clinics
- Other End Users
REST OF EUROPE: AUTOIMMUNITY DIAGNOSTICS MARKET, BY END USER, 2023–2031
| Segment | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 162.8 | 173.7 | 186.8 | 201.9 | 240 | 264.5 | 293.6 | 329.3 | 9.9 |
| HOSPITALS & CLINICS | 108 | 114.2 | 121.6 | 130.3 | 152.1 | 166.2 | 182.9 | 203.3 | 8.9 |
| OTHER END USERS | 37.4 | 39.2 | 41.5 | 44.1 | 50.8 | 55.1 | 60.2 | 66.5 | 8.2 |
| TOTAL | 308.2 | 327.1 | 349.9 | 376.4 | 442.8 | 485.7 | 536.7 | 599 | 9.4 |
EUROPE: AUTOIMMUNITY DIAGNOSTICS MARKET, BY END USER, 2023–2031
| Segment | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 787 | 833 | 888.2 | 952.3 | 1112.8 | 1216 | 1338.5 | 1487.8 | 9 |
| HOSPITALS & CLINICS | 566 | 591.4 | 622.7 | 659.4 | 752 | 812 | 883.3 | 970.5 | 7.7 |
| OTHER END USERS | 208.9 | 215.5 | 224 | 234.1 | 260.1 | 277.2 | 297.7 | 322.9 | 6.3 |
| TOTAL | 1561.9 | 1639.9 | 1734.9 | 1845.9 | 2124.9 | 2305.3 | 2519.5 | 2781.2 | 8.2 |
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need Europe-specific market data to develop regional product strategies, identify growth opportunities in high-performing markets like UK and Germany, and optimize market entry approaches.
- Healthcare Investment Firms : Private equity and venture capital investors require detailed European market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging diagnostic technology leaders.
- Hospital & Laboratory Networks : Clinical laboratory operators and hospital systems need market intelligence to benchmark diagnostic service offerings, evaluate technology investments, and align procurement strategies with regional market trends.
- Pharmaceutical & Biotech Companies : Pharma firms developing autoimmune therapeutics require diagnostic market insights to understand companion diagnostic opportunities, patient stratification needs, and commercial partnerships across European markets.
- Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors need comprehensive European market data to support client strategy development, market entry planning, and competitive positioning in the diagnostics sector.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| UK | USD 942.3 Million |
| Germany | USD 684.8 Million |
| France | USD 131.7 Million |
| Italy | USD 153.6 Million |
| Spain | USD 103.4 Million |
| Rest Of Europe | USD 445.5 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Insights : Gain detailed understanding of Europe's $1,216 million autoimmunity diagnostics market with country-level breakdowns, competitive dynamics, and regional growth drivers specific to Western, Central, and Eastern European markets.
- Growth Forecasting : Access comprehensive 5-year projections showing market expansion to $1,986 million by 2030 at 8.5% CAGR, enabling strategic planning and investment decisions aligned with European market trajectory.
- Regulatory & Reimbursement Analysis : Understand Europe's complex regulatory landscape, CE marking requirements, and country-specific reimbursement policies that impact market entry, pricing strategies, and commercial success across the region.
- Competitive Landscape : Identify leading diagnostic providers, emerging players, and market consolidation trends in Europe's autoimmunity diagnostics sector to benchmark performance and identify partnership opportunities.
- Technology & Innovation Trends : Discover adoption rates of advanced diagnostic technologies including multiplex assays, automation, and digital health solutions driving market growth and clinical practice transformation across European healthcare systems.
Frequently asked questions
What is the current size of Europe's autoimmunity diagnostics market?
Europe's autoimmunity diagnostics market is valued at $1,216 million in 2025 and is projected to reach $1,986 million by 2030.
What is the expected growth rate for Europe's autoimmunity diagnostics market?
Europe's autoimmunity diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2030.
What factors are driving growth in Europe's autoimmunity diagnostics market?
Key drivers include Europe's advanced healthcare infrastructure, rising prevalence of autoimmune disorders, aging populations, improved disease awareness, and increasing adoption of innovative diagnostic technologies.
Which diagnostic technologies are gaining traction in Europe?
Europe is seeing increased adoption of multiplex assays, point-of-care testing, digital health-integrated diagnostics, and advanced serological testing platforms.
How does Europe's market compare to global autoimmunity diagnostics growth?
Europe's 8.5% CAGR slightly exceeds the global average of 8.3%, reflecting the region's strong healthcare investment and diagnostic infrastructure.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the autoimmunity diagnostics market. Exhaustive secondary research was done to collect information on the autoimmunity diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the autoimmunity diagnostics market.
Secondary Research
Various sources were utilized to gather information for this study in the secondary research process. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott Laboratories (US) | Product Specialist |
| Thermo Fisher Scientific Inc. (US) | Clinical Sales Specialist |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the autoimmunity diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry were identified through extensive secondary research.
- Primary and secondary research determined the revenues generated by leading players operating in the autoimmunity diagnostics market.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Autoimmune diseases are defined as a medical condition in which an individual's immune system produces antibodies that attack the body's normal tissues. autoimmunity diagnostics systematically identifies autoimmune disorders through clinical assessment and laboratory investigations to detect immune system dysfunction. This process typically involves routine laboratory testing, measurement of systemic inflammatory markers, detection of disease-specific autoantibodies, urinalysis, and other specialized immunologic assays.
Stakeholders
- Manufacturers & distributors of autoimmunity diagnostics products
- Clinical laboratories
- Hospitals
- Research institutes
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global autoimmunity diagnostics market, by product, test type, disease type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall autoimmunity diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
Get the Full Autoimmunity Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Autoimmunity Diagnostics Market.
- Rest Of Asia Pacific Autoimmunity Diagnostics Market
- US Autoimmunity Diagnostics Market
- Canada Autoimmunity Diagnostics Market
- UK Autoimmunity Diagnostics Market
- Germany Autoimmunity Diagnostics Market
- France Autoimmunity Diagnostics Market
- Italy Autoimmunity Diagnostics Market
- Spain Autoimmunity Diagnostics Market
- China Autoimmunity Diagnostics Market
- Japan Autoimmunity Diagnostics Market
- India Autoimmunity Diagnostics Market
- Australia Autoimmunity Diagnostics Market
- Rest Of Europe Autoimmunity Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
